Want to get a tough sample, like lung, looking like this? Read more!
www.biorxiv.org/content/10.1...
Want to get a tough sample, like lung, looking like this? Read more!
www.biorxiv.org/content/10.1...
You got it:
currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...
You got it:
currentprotocols.onlinelibrary.wiley.com/doi/10.1002/...
One for the ages.
#LaVuelta25
One for the ages.
#LaVuelta25
A funny backstory to this is that Milstein tried to patent the finding, however, the MRC concluded that they were unable to "identify any immediate applications"..
Oopsie 🤦♂️
go.nature.com/3Jr4Q8R
A funny backstory to this is that Milstein tried to patent the finding, however, the MRC concluded that they were unable to "identify any immediate applications"..
Oopsie 🤦♂️
It took me a moment to realize they meant "autumn," not the collapse of civilization.
It took me a moment to realize they meant "autumn," not the collapse of civilization.
Fifty years of monoclonals: the past, present and future of antibody therapeutics
www.nature.com/articles/s41...
Fifty years of monoclonals: the past, present and future of antibody therapeutics
www.nature.com/articles/s41...
www.biorxiv.org/content/10.1...
www.biorxiv.org/content/10.1...
www.science.org/content/arti...
www.science.org/content/arti...
@alastaircampbell2.bsky.social and Rory are joined by Sir Alex Younger to discuss:
🇺🇦What will happen to Ukraine if America withdraws all support?
🇷🇺Why Russia is conducting ceasefire negotiations badly
🇹🇼What if China invades Taiwan?
We show that a substantial proportion of a widely used TCR-pMHC database does not functionally validate, causing underestimation of performance of TCR-pMHC prediction models.
www.biorxiv.org/content/10.1...
A billion dollars later, he told us his story in 2018
A billion dollars later, he told us his story in 2018